Role of miR-107 and its signaling pathways in diseases

References

• Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005;33:1290–7
   PubMed Web of Science ®Google Scholar
• Polster BJ, Westaway SK, Nguyen TM, et al. Discordant expression of miR-103/7 and pantothenate kinase host genes in mouse. Mol Genet Metab 2010;101:292–5
   PubMed Web of Science ®Google Scholar
• Noren Hooten N, Abdelmohsen K, Gorospe M, et al. microRNA expression patterns reveal differential expression of target genes with age. PLoS One 2010;5:e10724
   PubMed Web of Science ®Google Scholar
• Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008;28:1213–23
   PubMed Web of Science ®Google Scholar
• Nelson PT, Wang WX. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. J Alzheimers Dis 2010;21:75–9
   PubMed Web of Science ®Google Scholar
• Wang WX, Wilfred BR, Madathil SK, et al. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 2010;177:334–45
   PubMed Web of Science ®Google Scholar
• Yao J, Hennessey T, Flynt A, et al. MicroRNA-related cofilin abnormality in Alzheimer's disease. PLoS One 2010;5:e15546
   PubMed Web of Science ®Google Scholar
• Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 2009;15:287–93
   PubMed Web of Science ®Google Scholar
• Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol 2012;13:239–50
   PubMed Web of Science ®Google Scholar
• Foley NH, O'Neill LA. miR-107: a toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes. J Leukoc Biol 2012;92:521–7
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Forrest AR, Maeno E, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009;4:e6677
   PubMed Web of Science ®Google Scholar
• Pallasch CP, Patz M, Park YJ, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009;114:3255–64
   PubMed Web of Science ®Google Scholar
• Lee KH, Lotterman C, Karikari C, et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009;9:293–301
   PubMed Web of Science ®Google Scholar
• Datta J, Smith A, Lang JC, et al. microRNA-107 functions as a candidate tumor-suppressor gene in head and neck squamous cell carcinoma by downregulation of protein kinase Cvarepsilon. Oncogene 2012;31:4045–53
   PubMed Web of Science ®Google Scholar
• Bryant RJ, Pawlowski T, Catto JW, et al. Changes in circulating microRNA levels associated with prostate cancer. Br J Cancer 2012;106:768–74
   PubMed Web of Science ®Google Scholar
• Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008;47:1955–63
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, et al. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008;14:2588–92
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Shi Y, et al. MicroRNA-107, an oncogene microRNA that regulates tumour invasion and metastasis by targeting DICER1 in gastric cancer. J Cell Mol Med 2011;15:1887–95
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Y, Zhang H, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011;9:824–33
   PubMed Web of Science ®Google Scholar
• Feng L, Xie Y, Zhang H, Wu Y. miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells. Med Oncol 2012;29:856–63
   PubMed Web of Science ®Google Scholar
• Ayala de la Pena F, Kanasaki K, Kanasaki M, et al. Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem 2011;286:20778–87
   PubMed Web of Science ®Google Scholar
• Trivellin G, Butz H, Delhove J, et al. MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab 2012;303:E708–19
   PubMed Web of Science ®Google Scholar
• Chen L, Chen XR, Chen FF, et al. MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell Mol Neurobiol 2013;33:651–7
   PubMed Web of Science ®Google Scholar
• Paraskevi A, Theodoropoulos G, Papaconstantinou I, et al. Circulating microRNA in inflammatory bowel disease. J Crohns Colitis 2012;6:900–4
   PubMed Web of Science ®Google Scholar
• Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677–84
   PubMed Web of Science ®Google Scholar
• Dolt KS, Mishra MK, Karar J, et al. cDNA cloning, gene organization and variant specific expression of HIF-1 alpha in high altitude yak (Bos grunniens). Gene 2007;386:73–80
   PubMed Web of Science ®Google Scholar
• Wang WX, Wilfred BR, Hu Y, et al. Anti-argonaute RIP-Chip shows that miRNA transfections alter global patterns of mRNA recruitment to microribonucleoprotein complexes. RNA 2010;16:394–404
   Google Scholar
• Yamakuchi M, Lotterman CD, Bao C, et al. P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad Sci USA 2010;107:6334–9
   PubMed Web of Science ®Google Scholar
• Cicatiello L, Mutarelli M, Grober OM, et al. Estrogen receptor alpha controls a gene network in luminal-like breast cancer cells comprising multiple transcription factors and microRNAs. Am J Pathol 2010;176:2113–30
   PubMed Web of Science ®Google Scholar
• Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 2010;5:e10615
   PubMed Web of Science ®Google Scholar
• Bohlig L, Friedrich M, Engeland K. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res 2011;39:440–53
   PubMedGoogle Scholar
• Park JH, Ahn J, Kim S, et al. Murine hepatic miRNAs expression and regulation of gene expression in diet-induced obese mice. Mol Cells 2011;31:33–8
   PubMed Web of Science ®Google Scholar
• Moncini S, Salvi A, Zuccotti P, et al. The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration. PLoS One 2011;6:e20038
   PubMedGoogle Scholar
• Naar AM. MiRs with a sweet tooth. Cell Metab 2011;14:149–50
   PubMed Web of Science ®Google Scholar
• Chen PS, Su JL, Cha ST, et al. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. J Clin Invest 2011;121:3442–55
   PubMed Web of Science ®Google Scholar
• Inoue T, Iinuma H, Ogawa E, et al. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012;27:1759–64
   PubMed Web of Science ®Google Scholar
• Chen HY, Lin YM, Chung HC, et al. miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4. Cancer Res 2012;72:3631–41
   PubMed Web of Science ®Google Scholar
• Zhang SY, Surapureddi S, Coulter S, et al. Human CYP2C8 is post-transcriptionally regulated by microRNAs 103 and 107 in human liver. Mol Pharmacol 2012;82:529–40
   PubMed Web of Science ®Google Scholar
• Meng S, Cao J, Wang L, et al. MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1beta. PLoS One 2012;7:e40323
   Web of Science ®Google Scholar
• Chen L, Zhang R, Li P, et al. P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. Neurosci Lett 2013;534:327–32
   PubMed Web of Science ®Google Scholar
• Chen L, Chen XR, Zhang R, et al. MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression. J Neurooncol 2013;112:59–66
   PubMed Web of Science ®Google Scholar
• Scarr E, Craig JM, Cairns MJ, et al. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA. Transl Psychiatry 2013;3:e230
   Web of Science ®Google Scholar
• Neijenhuis S, Bajrami I, Miller R, et al. Identification of miRNA modulators to PARP inhibitor response. DNA Repair (Amst) 2013;12:394–402
   PubMed Web of Science ®Google Scholar
• He J, Zhang W, Zhou Q, et al. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell Biol 2013;45:1962–73
   PubMed Web of Science ®Google Scholar
• Ramaiah MJ, Pushpavalli SN, Lavanya A, et al. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis. Bioorg Med Chem Lett 2013;23:5699–706
   PubMed Web of Science ®Google Scholar
• Xue X, Cao AT, Cao X, et al. Downregulation of MicroRNA-107 in intestinal CD11c, myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur J Immunol 2013. [Epub ahead of print]
   Google Scholar